We are live on ! Find out more
RVMDW icon

Revolution Medicines Inc Warrant
RVMDW

22 hedge funds and large institutions have $2.46M invested in Revolution Medicines Inc Warrant in 2025 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

12% more capital invested

Capital invested by funds: $2.2M → $2.46M (+$254K)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0.1% less ownership

Funds ownership: 73.17% → 73.07% (-0.1%)

4% less funds holding

Funds holding: 23 → 22 (-1)

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
22
Holders Change
-1
Holders Change %
-4.35%
% of All Funds
0.29%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
–
Increased
1
Reduced
2
Closed
1
Calls
$26K
Puts
–
Net Calls
+$26K
Net Calls Change
+$3K

Top Buyers

Rank Fund Capital Flow
1
AC
Aristeia Capital
Connecticut
+$28.6K

Top Sellers

Rank Fund Capital Flow
1
CF
Cantor Fitzgerald
New York
-$28.8K
2
CL
CSS LLC
Illinois
-$3.98K
3
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$816
Name Holding Trade Value Shares
Change 		Change in
Stake
LP
1
LMR Partners
United Kingdom
$794K – – –
D.E. Shaw & Co
2
D.E. Shaw & Co
New York
$436K – – –
T. Rowe Price Associates
3
T. Rowe Price Associates
Maryland
$179K -$816 -3,366 -0.6%
Adage Capital Partners
4
Adage Capital Partners
Massachusetts
$150K – – –
LC
5
Lunate Capital
United Arab Emirates
$135K – – –
AC
6
Aristeia Capital
Connecticut
$122K +$28.6K +117,908 +38%
SCM
7
Soros Capital Management
New York
$109K – – –
PA
8
Perceptive Advisors
New York
$75K – – –
Toronto Dominion Bank
9
Toronto Dominion Bank
Ontario, Canada
$66.4K – – –
BL
10
Bleichroeder LP
New York
$60K – – –
CL
11
CSS LLC
Illinois
$52.4K -$3.98K -16,402 -46%
SC
12
Sculptor Capital
New York
$50.3K – – –
DIM
13
DLK Investment Management
California
$49.3K – – –
DKCM
14
Davidson Kempner Capital Management
New York
$45K – – –
DCM
15
Driehaus Capital Management
Illinois
$40.5K – – –
FCM
16
Farallon Capital Management
California
$36K – – –
WAM
17
Weiss Asset Management
Massachusetts
$22.1K – – –
WAM
18
Wolverine Asset Management
Illinois
$21.1K – – –
TD Asset Management
19
TD Asset Management
Ontario, Canada
$12.2K – – –
TWC
20
TD Waterhouse Canada
Ontario, Canada
$130 – – –
Osaic Holdings
21
Osaic Holdings
Arizona
$18 – – –
CF
22
Cantor Fitzgerald
New York
– -$28.8K -109,617 Closed

RVMDW Hedge Fund Activity: Q3 2025 in Review

22 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in Revolution Medicines Inc Warrant (RVMDW) for Q3 2025, worth a combined $2.46M — up 12% from $2.2M a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of RVMDW and 0 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 1 added.

The largest buyer was Aristeia Capital, adding an estimated $28.6K. The largest seller was Cantor Fitzgerald, exiting entirely with an estimated $28.8K sold.

  • 22 institutional investors held Revolution Medicines Inc Warrant (RVMDW) as of Q3 2025, down from 23 in Q2 2025.
  • Funds reported $2.46M of Revolution Medicines Inc Warrant stock for Q3 2025, up 12% quarter-over-quarter.
  • 0 funds opened new Revolution Medicines Inc Warrant positions in Q3 2025 and 1 closed out, a net change of -1 holder.
  • The largest Revolution Medicines Inc Warrant buyer in Q3 2025 was Aristeia Capital, an estimated $28.6K added.
  • The largest Revolution Medicines Inc Warrant seller in Q3 2025 was Cantor Fitzgerald, an estimated $28.8K sold.

Based on aggregated 13F filings for Q3 2025.